Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia & GRAPEVINE, Texas — Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards…

VANCOUVER, British Columbia and GRAPEVINE, Texas -- Alpha Cognition Inc., a biopharmaceutical company focusing on developing innovative therapies for debilitating neurodegenerative disorders, announced on October 1, 2026, that the Compensation Committee of its Board of Directors granted inducement awards to a new non-executive employee.

These awards were in the form of nonstatutory stock options to purchase 6,000 shares of the company's common stock. The 2026 Inducement Grant Plan utilized by the company specifically targets equity awards for individuals who were not previously employed by the company. The Compensation Committee determined that the stock options served as an inducement for the new employee to join the company, in compliance with Nasdaq Listing Rule 5635(c)(4).

Written by urgent.news from Financial Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at financialpost.com →

More in Finance & Markets

More from Friday 2 October →